Synthesis, in vitro pharmacology, and pharmacokinetic profiles of 2-[1-amino-1-carboxy-2-(9H-xanthen-9-yl)-ethyl]-1-fluorocyclopropanecarboxylic acid and its 6-heptyl ester, a potent mGluR2 antagonist

Add time:08/27/2019    Source:sciencedirect.com

In this paper, we describe the synthesis of (+)-(1R∗,2R∗)-2-[(1S∗)-1-amino-1-carboxy-2-(9H-xanthen-9-yl)-ethyl]-1-fluorocyclopropanecarboxylic acid (+)-16a, a compound, that is, fluorinated at the alpha position of the carboxylic acid in the cyclopropane ring of a group II mGluRs antagonist, 1 (LY341495), using a previously reported stereoselective cyclopropanation reaction. The fluorinated compound (+)-16a exhibited almost the same affinity (IC50 = 3.49 nM) for mGluR2 as 1 but had a superior pharmacokinetic profile. Furthermore, a marked elevation of the plasma levels of (+)-16a was observed following the administration of a prodrug, (+)-17.

We also recommend Trading Suppliers and Manufacturers of ETHYL N-(2-HEPTYL)-P-AMINOBENZOATE (cas 132666-33-2). Pls Click Website Link as below: cas 132666-33-2 suppliers

Prev:Short-term oral toxicity of butyl ether, ethyl hexyl ether, methyl heptyl ether and 1,6-dimethoxyhexane in male rats and the role of 2-methoxyacetic acid
Next:Pyrolysis of n-pentane, n-hexane and n-heptane in a single pulse shock tube)